PREVALENCE AND FORMS OF NEUROPATHIC MORBIDITY IN 800 DIABETICS

PREVALENCE AND FORMS OF NEUROPATHIC MORBIDITY IN 800 DIABETICS
复制标题

DOI:
10.1007/bf02965972
复制
发表时间:
1994-03-01
影响因子:
2.1
通讯作者:
GEOGHEGAN, M
GEOGHEGAN, M
中科院分区:
医学4区
文献类型:
--
作者:
OHARE, JA;ABUAISHA, F;GEOGHEGAN, M

文献摘要

被引文献

相似文献

我们前瞻性地确定了800例糖尿病患者(336例1型糖尿病,464例2型糖尿病)在一年内各种形式的糖尿病神经病变的发病率。记录的症状为:足部疼痛/感觉异常、感觉丧失和不宁腿综合征。我们还记录了神经性溃疡、肌萎缩、足下垂和眼麻痹的患病率。记录的自主神经症状包括:阳痿、体位性低血压和腹泻。100名非糖尿病对照受试者报告的唯一症状是:2%的感觉丧失和7%的不宁腿综合征。在糖尿病患者中,13%存在疼痛/感觉异常,7%存在感觉丧失,2%存在神经性溃疡。糖尿病性肌萎缩(近端股神经病变)的患病率为0.8%,眼肌麻痹0.1%,腓神经麻痹0.1%。20%的患者出现勃起功能障碍,1%出现症状性体位性低血压,1%出现糖尿病腹泻。总的来说,22.9%的人口受到一个或多个由神经病变引起的问题的困扰。两组糖尿病患者的神经病变均与年龄较大(p < 0.001)和严重视网膜病变(p < 0.001)相关,1型糖尿病患者的神经病变与糖尿病病程、蛋白尿(p < 0.02)、高血压(p < 0.01)和缺血性心脏病(p < 0.02)相关。
We prospectively determined the prevalence of morbidity from the various forms of diabetic neuropathy over one year in a population of 800 patients with diabetes mellitus (336 type 1, 464 type 2 DM). Symptoms documented were: pain/paraesthesia in the feet, loss of feeling and the restless legs syndrome. We also documented the prevalence of: neuropathic ulcers, amyotrophy, foot drop, and oculomotor palsy. Autonomic symptoms documented were: impotence, postural hypotension and diarrhoea. The only symptoms reported by 100 non-diabetic control subjects were: loss of feeling in 2% and restless legs syndrome in 7%. In the diabetics; pain/paraesthesia was present in 13%, feeling loss in 7% and neuropathic ulcers in 2% . The prevalence of Diabetic amyotrophy (proximal femoral neuropathy) was 0.8%, oculomotor palsy 0.1% and peroneal nerve palsy 0.1%. Erectile impotence was present in 20%, symptomatic postural hypotension in 1% and diabetic diarrhoea in 1%. Overall; 22.9% of the population was afflicted by one or more problems resulting from neuropathy. Neuropathy was associated with older age (p < 0.001), and serious retinopathy (p < 0.001) in both groups of diabetics and with duration of diabetes, proteinuria (p < 0.02), hypertension (p < 0.01) and ischaemic heart disease (p < 0.02) in type 1 diabetics.